← Leaderboards
Guan Xu
University Of Michigan At Ann Arbor
$4,645,233
Attributed
$6,132,305
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,132,305 · 3
By mechanism
R37$3,158,161 · 1
R01$2,577,594 · 1
R21$396,550 · 1
Top collaborators
- Peter D.R. Higgins7 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Peter D.r. Higgins$8,554,780
- Ellen M. Zimmermann$3,167,259
- Ryan William Stidham$3,043,991
- Xueding Wang$13,305,921
- Jonathan Russell Dillman$1,397,457
Others in their field
Top investigators on “Biopsy”
- David Heimbrook · Leidos Biomedical Research, Inc.$97,871,847
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ralph Parchment · Leidos Biomedical Research, Inc.$43,674,966
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Peter Scott Heeger · Case Western Reserve University$37,822,090
Research focus
BiopsyAnimal ModelDiagnosticPathologySignal TransductionOpticsHemoglobinTissuesIn VivoPerformanceSamplingProceduresCollagenMagnetic Resonance ImagingDiagnostic ProcedureExcisionMeasurementSensitivity And SpecificityMolecularHuman SubjectHuman TissueFutureIn Vivo ModelPilot Projects
Grant awards (14)
Real time fine needle assessment of architectural heterogeneity in prostate cancer$463,964
R37 · FY2025 · CA · contact PI
Assessing biomarkers of intestinal fibrosis and inflammation in Crohn's Disease via an endoscopic imaging catheter$509,929
R01 · FY2024 · DK
Real time fine needle assessment of architectural heterogeneity in prostate cancer$449,106
R37 · FY2024 · CA · contact PI
Assessing biomarkers of intestinal fibrosis and inflammation in Crohn's Disease via an endoscopic imaging catheter$516,187
R01 · FY2023 · DK
Real time fine needle assessment of architectural heterogeneity in prostate cancer$469,236
R37 · FY2023 · CA · contact PI
Assessing biomarkers of intestinal fibrosis and inflammation in Crohn's Disease via an endoscopic imaging catheter$529,415
R01 · FY2022 · DK
Real time fine needle assessment of architectural heterogeneity in prostate cancer$486,336
R37 · FY2022 · CA · contact PI
Assessing biomarkers of intestinal fibrosis and inflammation in Crohn's Disease via an endoscopic imaging catheter$491,260
R01 · FY2021 · DK
Real time fine needle assessment of architectural heterogeneity in prostate cancer$458,577
R37 · FY2021 · CA · contact PI
Assessing biomarkers of intestinal fibrosis and inflammation in Crohn's Disease via an endoscopic imaging catheter$530,803
R01 · FY2020 · DK
Real time fine needle assessment of architectural heterogeneity in prostate cancer$477,180
R37 · FY2020 · CA · contact PI
Real time fine needle assessment of architectural heterogeneity in prostate cancer$353,762
R37 · FY2019 · CA · contact PI
In vivo photoacoustic biopsy for intestinal strictures in Crohn's disease$193,750
R21 · FY2017 · AI · contact PI
In vivo photoacoustic biopsy for intestinal strictures in Crohn's disease$202,800
R21 · FY2016 · AI · contact PI